The total number of records retrieved from this search are 6. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_5231	Virus nameParovirus	Virus strainwild type	Virus genome typeDNA	Virus familyParoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman mesothelioma cell line	Cell lineNCI-H2052	Concentration of cell line5.0E+3 cells per well	In-vitro toxicityNA	AssayMTS assay	In-vitro virus concentration10 VP per cell	In-vitro result90% cell viable	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27783867
IDOV_5232	Virus nameParovirus	Virus strainwild type	Virus genome typeDNA	Virus familyParoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman mesothelioma cell line	Cell lineNCI-H2052	Concentration of cell line5.0E+3 cells per well	In-vitro toxicityNA	AssayMTS assay	In-vitro virus concentration100 VP per cell	In-vitro result80% cell viable	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27783867
IDOV_5233	Virus nameParovirus	Virus strainwild type	Virus genome typeDNA	Virus familyParoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman mesothelioma cell line	Cell lineNCI-H2052	Concentration of cell line5.0E+3 cells per well	In-vitro toxicityNA	AssayMTS assay	In-vitro virus concentration1000 VP per cell	In-vitro result80% cell viable	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27783867
IDOV_5243	Virus nameParovirus	Virus strainAd5/3VEGFE1-delta	Virus genome typeDNA	Virus familyParoviridae	Virus genome modificationDeletion mutant for E1A gene and expressing VEGF gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman mesothelioma cell line	Cell lineNCI-H2052	Concentration of cell line5.0E+3 cells per well	In-vitro toxicityNA	AssayMTS assay	In-vitro virus concentration10 VP per cell	In-vitro result90% cell viable	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27783867
IDOV_5244	Virus nameParovirus	Virus strainAd5/3VEGFE1-delta	Virus genome typeDNA	Virus familyParoviridae	Virus genome modificationDeletion mutant for E1A gene and expressing VEGF gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman mesothelioma cell line	Cell lineNCI-H2052	Concentration of cell line5.0E+3 cells per well	In-vitro toxicityNA	AssayMTS assay	In-vitro virus concentration100 VP per cell	In-vitro result90% cell viable	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27783867
IDOV_5245	Virus nameParovirus	Virus strainAd5/3VEGFE1-delta	Virus genome typeDNA	Virus familyParoviridae	Virus genome modificationDeletion mutant for E1A gene and expressing VEGF gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman mesothelioma cell line	Cell lineNCI-H2052	Concentration of cell line5.0E+3 cells per well	In-vitro toxicityNA	AssayMTS assay	In-vitro virus concentration1000 VP per cell	In-vitro result100% cell killing	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27783867